Skip to content
MedsAcross

Manufacturer

Waylis Therapeutics

Products listed
25
Molecules
11
Therapy areas
5

Waylis Therapeutics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 25 of its products across 11 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
Also listed as
Waylis Therapeutics LLC
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Waylis Therapeutics products through licensed channels, with the documents your regulator needs.

Cardiology

8 presentations

Cardiology overview
MedicineActive ingredientRegisterAvailability
Coreg 12.5 mg tabletOralCarvedilolUS FDAAvailable on request
Coreg 25 mg tabletOralCarvedilolUS FDAAvailable on request
Coreg 3.125 mg tabletOralCarvedilolUS FDAAvailable on request
Coreg 6.25 mg tabletOralCarvedilolUS FDAAvailable on request
Coreg CR 10 mg extended-release capsuleOralCarvedilolUS FDAAvailable on request
Coreg CR 20 mg extended-release capsuleOralCarvedilolUS FDAAvailable on request
Coreg CR 40 mg extended-release capsuleOralCarvedilolUS FDAAvailable on request
Coreg CR 80 mg extended-release capsuleOralCarvedilolUS FDAAvailable on request

Oncology

8 presentations

Oncology overview
MedicineActive ingredientRegisterAvailability
Droxia 200 mg capsuleOralHydroxyureaUS FDAAvailable on request
Droxia 300 mg capsuleOralHydroxyureaUS FDAAvailable on request
Droxia 400 mg capsuleOralHydroxyureaUS FDAAvailable on request
Eulexin 125 mg capsuleOralFlutamideUS FDAAvailable on request
Hydrea 500 mg capsuleOralHydroxyureaUS FDAAvailable on request
Leukeran 2 mg tabletOral Cold chainChlorambucilUS FDAAvailable on request
Myleran 2 mg tabletOralBusulfanUS FDAAvailable on request
Tabloid 40 mg tabletOralThioguanineUS FDAAvailable on request

Psychiatry

6 presentations

Psychiatry overview
MedicineActive ingredientRegisterAvailability
Lunesta 1 mg tabletOralEszopicloneUS FDAAvailable on request
Lunesta 2 mg tabletOralEszopicloneUS FDAAvailable on request
Lunesta 3 mg tabletOralEszopicloneUS FDAAvailable on request
Valium 10 mg tabletOralDiazepamUS FDAAvailable on request
Valium 2 mg tabletOralDiazepamUS FDAAvailable on request
Valium 5 mg tabletOralDiazepamUS FDAAvailable on request

Gastroenterology

1 presentation

Gastroenterology overview
MedicineActive ingredientRegisterAvailability
Humatin 250 mg capsuleOralParomomycinUS FDAAvailable on request

Nephrology and urology

1 presentation

Nephrology and urology overview
MedicineActive ingredientRegisterAvailability
Jalyn 0.5 mg/0.4 mg capsuleOralDutasteride and TamsulosinUS FDAAvailable on request

Other products

1 presentation

MedicineActive ingredientRegisterAvailability
Aciphex 20 mg delayed-release tabletOralRabeprazoleUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Waylis Therapeutics

Send a request for any of these products. We confirm the licensed source, documents and lead time.